{"DataElement":{"publicId":"6425397","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Cerebrovascular Accident Type","preferredDefinition":"A description of the common toxicity criteria adverse event cerebrovascular accident.","longName":"6425389v1.0:6425113v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6425389","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Cerebrovascular Accident","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event._A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","longName":"2480706v1.0:3236610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3236610","version":"1","preferredName":"Cerebrovascular Accident","preferredDefinition":"A sudden loss of neurologic function secondary to hemorrhagic or ischemia in the brain parenchyma due to a vascular event. Infarction or hemorrhage may be demonstrated either directly by imaging,laboratory, or pathologic examination in patients with symptom duration less than 24 hours, or inferred by symptoms lasting greater than or equal to 24 hours (or fatal within 24 hours) that cannot be attributed to another cause.  Diagnostic tests include CT scan, MRI, angiography, and EEG to locate and evaluate the extent of the hemorrhagic or ischemic damage in the brain parenchyma, coagulation studies, complete blood count, comprehensive metabolic panel, and urinalysis.","longName":"C3390","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3BB9E31-3D0E-697A-E040-BB89AD4345E7","latestVersionIndicator":"Yes","beginDate":"2011-05-20","endDate":null,"createdBy":"LUY","dateCreated":"2011-05-20","modifiedBy":"ONEDATA","dateModified":"2011-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538C74D-25D8-3463-E053-F662850A55D1","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2018-10-23","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6425113","version":"1","preferredName":"Cerebrovascular Accident Type","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event._Something distinguishable as an identifiable class based on common qualities.","longName":"6425113v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ischemic","valueDescription":"Ischemic Cerebrovascular Accident","ValueMeaning":{"publicId":"3236724","version":"1","preferredName":"Ischemic Cerebrovascular Accident","longName":"3236724","preferredDefinition":"A sudden loss of neurological function secondary to ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ischemic Stroke","conceptCode":"C95802","definition":"An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3BC4428-F110-7327-E040-BB89AD4301BA","latestVersionIndicator":"Yes","beginDate":"2011-05-20","endDate":null,"createdBy":"LUY","dateCreated":"2011-05-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7535C691-E3FE-0560-E053-F662850A6A22","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"ONEDATA","dateModified":"2018-09-06","deletedIndicator":"No"},{"value":"Hemorrhagic","valueDescription":"Hemorrhagic Cerebrovascular Accident","ValueMeaning":{"publicId":"6425114","version":"1","preferredName":"Hemorrhagic Cerebrovascular Accident","longName":"6425114","preferredDefinition":"An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhagic Stroke","conceptCode":"C95803","definition":"An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7535C691-E408-0560-E053-F662850A6A22","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"ONEDATA","dateModified":"2018-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7535C691-E421-0560-E053-F662850A6A22","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"ONEDATA","dateModified":"2018-09-06","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAF949E-BF23-5675-E053-4EBD850AD63F","beginDate":"2021-03-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-29","modifiedBy":"ONEDATA","dateModified":"2021-03-29","deletedIndicator":"No"},{"value":"Transient ischemic attack","valueDescription":"Transient Ischemic Attack","ValueMeaning":{"publicId":"2944400","version":"1","preferredName":"Transient Ischemic Attack","longName":"2944400","preferredDefinition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transient Ischemic Attack","conceptCode":"C50781","definition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7431FEA7-FCE7-A5C9-E040-BB89AD4324B4","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"ONEDATA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAF949E-BF37-5675-E053-4EBD850AD63F","beginDate":"2021-03-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-29","modifiedBy":"ONEDATA","dateModified":"2021-03-29","deletedIndicator":"No"},{"value":"Silent stroke","valueDescription":"Silent Stroke","ValueMeaning":{"publicId":"7319549","version":"1","preferredName":"Silent Stroke","longName":"7319549","preferredDefinition":"An asymptomatic cerebral infarction that was incidentally noted by T2 or fluid-attenuated inversion recovery (FLAIR) hyperintensities on an MRI of the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Silent Stroke","conceptCode":"C172675","definition":"An asymptomatic cerebral infarction that was incidentally noted by T2 or fluid-attenuated inversion recovery (FLAIR) hyperintensities on an MRI of the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A79B3FA4-B478-44B6-E053-4EBD850AB59E","latestVersionIndicator":"Yes","beginDate":"2020-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-08","modifiedBy":"ONEDATA","dateModified":"2020-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAF949E-BF41-5675-E053-4EBD850AD63F","beginDate":"2021-03-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-29","modifiedBy":"ONEDATA","dateModified":"2021-03-29","deletedIndicator":"No"},{"value":"Overt Stroke","valueDescription":"Overt Stroke","ValueMeaning":{"publicId":"7319550","version":"1","preferredName":"Overt Stroke","longName":"7319550","preferredDefinition":"A cerebral infarction that is evident by new neurological symptoms lasting greater than 24 hours or having an area of diffusion restriction or a T2 or fluid-attenuated inversion recovery (FLAIR) hyperintensity on an MRI of the brain that was consistent with the neurological findings.\r\n\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overt Stroke","conceptCode":"C172674","definition":"A cerebral infarction that is evident by new neurological symptoms lasting greater than 24 hours or having an area of diffusion restriction or a T2 or fluid-attenuated inversion recovery (FLAIR) hyperintensity on an MRI of the brain that was consistent with the neurological findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A79B3FA4-B4A7-44B6-E053-4EBD850AB59E","latestVersionIndicator":"Yes","beginDate":"2020-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-08","modifiedBy":"ONEDATA","dateModified":"2020-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAF949E-BF55-5675-E053-4EBD850AD63F","beginDate":"2021-03-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-29","modifiedBy":"ONEDATA","dateModified":"2021-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3236722","version":"1","preferredName":"Cerebrovascular Accident Type","preferredDefinition":"A sudden loss of neurologic function secondary to hemorrhagic or ischemia in the brain parenchyma due to a vascular event. Infarction or hemorrhage may be demonstrated either directly by imaging,laboratory, or pathologic examination in patients with symptom duration less than 24 hours, or inferred by symptoms lasting greater than or equal to 24 hours (or fatal within 24 hours) that cannot be attributed to another cause.  Diagnostic tests include CT scan, MRI, angiography, and EEG to locate and evaluate the extent of the hemorrhagic or ischemic damage in the brain parenchyma, coagulation studies, complete blood count, comprehensive metabolic panel, and urinalysis.:Type; a subdivision of a particular kind of thing.","longName":"C3390:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3BC4428-F0EB-7327-E040-BB89AD4301BA","latestVersionIndicator":"Yes","beginDate":"2011-05-20","endDate":null,"createdBy":"LUY","dateCreated":"2011-05-20","modifiedBy":"ONEDATA","dateModified":"2011-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7535C691-E3DE-0560-E053-F662850A6A22","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"MALUMK","dateModified":"2021-03-29","changeDescription":".PVs added for 2100r7. 03/29/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CPST_TOX_ctcae_cva_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the type of common t","type":"Preferred Question Text","description":"What was the type of common toxicity criteria adverse event cerebrovascular accident?","url":null,"context":"NHLBI"},{"name":"Type","type":"Alternate Question Text","description":"Type","url":null,"context":"NHLBI"},{"name":"Type","type":"Application Standard Question Text","description":"Type","url":null,"context":"NHLBI"},{"name":"Specify type of cerebral vascular accident","type":"Alternate Question Text","description":"Specify type of cerebral vascular accident","url":null,"context":"NHLBI"},{"name":"Specify type of cerebrovascular accident","type":"Alternate Question Text","description":"Specify type of cerebrovascular accident","url":null,"context":"NHLBI"},{"name":"Specify type of stroke","type":"Alternate Question Text","description":"Specify type of stroke","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538C74D-25EE-3463-E053-F662850A55D1","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"MALUMK","dateModified":"2021-03-29","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def. Added AQT for 4100r6. 10/27/2020 KMM. Added AQT for 4100r6. 11/05/2020 KMM. AQT added for 2100r7. 03/29/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}